News
With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...
Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...
Kirk Perry has been named interim CEO, effective immediately, as the board conducts a search for Mongon's permanent successor ...
Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...
Kenvue has five brands that generate over $1 billion in sales—Johnson’s, Neutrogena, Listerine, Tylenol, and Aveeno—as well as a number of brands that generate over $400 million in sales: Nicorette, ...
July 14 (UPI) -- Police in an Oklahoma town confirmed Monday that a farmer was killed by his own water buffalo last week.
All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director ...
Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.
Current Kenvue Director, Kirk Perry, is named Interim CEO, effective immediately. Kenvue Board of Directors appointed a new ...
American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...
Seeking Alpha's daily roundup of remarks and statements that could impact markets, sectors or individual stocks. Read more here.
Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results